1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Sage Therapeutics

Anonymous board for Sage Therapeutics

Sort By:
Title
Replies Views
Last Message
  1. anonymous
    Replies:
    9
    Views:
    799
  2. anonymous
    Replies:
    13
    Views:
    1,076
  3. anonymous
    Replies:
    7
    Views:
    939
  4. anonymous
    Replies:
    6
    Views:
    1,003
  5. anonymous
    Replies:
    5
    Views:
    1,033
  6. anonymous
    Replies:
    22
    Views:
    1,596
  7. anonymous
    Replies:
    46
    Views:
    3,766
  8. anonymous
    Replies:
    8
    Views:
    915
  9. anonymous
    Replies:
    13
    Views:
    999
  10. anonymous
    Replies:
    14
    Views:
    1,470
  11. anonymous
    Replies:
    9
    Views:
    1,187
  12. anonymous
    Replies:
    23
    Views:
    2,155
  13. anonymous
    Replies:
    46
    Views:
    3,933
  14. anonymous
    Replies:
    15
    Views:
    1,481
  15. anonymous
    Replies:
    6
    Views:
    1,043
  16. anonymous
    Replies:
    4
    Views:
    1,059
  17. anonymous
    Replies:
    8
    Views:
    894
  18. anonymous
    Replies:
    2
    Views:
    859
  19. anonymous
    Replies:
    5
    Views:
    1,454
  20. anonymous
    Replies:
    0
    Views:
    458

Thread Display Options

Loading...